{"id":"W4417497569","doi":"10.1080/14712598.2025.2606897","title":"Ranibizumab biosimilar (Oceva) – real-world experience from India (RORE study)","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Electrovaya (Canada)","funders":"","keywords":"Biosimilar; Ranibizumab; Population; Clinical trial; Pharmacogenetics; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004044228,0.0004464451,0.0006811064,0.0002017366,0.0003446095,0.00004297169,0.0006904612,0.000596192,0.003601214],"category_scores_gemma":[0.000144798,0.0002741765,0.0002485328,0.0005912301,0.0005163454,0.00005119306,0.000159819,0.0005146289,0.0001412644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007367494,"about_ca_system_score_gemma":0.0000413805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001855799,"about_ca_topic_score_gemma":0.000008832667,"domain_scores_codex":[0.99683,0.001002607,0.0005526345,0.0009845252,0.00008603193,0.0005441451],"domain_scores_gemma":[0.9983277,0.0007422443,0.0001238761,0.0006766299,0.00006578123,0.00006378415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009109007,0.007138268,0.1146916,0.000003132576,0.001444874,0.00003492215,0.003105458,9.320729e-7,0.4340442,0.01875356,0.06355545,0.3481187],"study_design_scores_gemma":[0.003433872,0.001618087,0.143321,0.00005333211,0.00000144959,0.000001174908,0.000976199,0.000003370343,0.08306164,0.001380983,0.7657099,0.0004389122],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9027239,0.04843424,0.0005689855,0.009208851,0.01010551,0.002596382,0.0001753253,0.0008662366,0.02532058],"genre_scores_gemma":[0.9431206,0.04481642,0.0006687379,0.01021109,0.0002052628,0.0001780807,0.00009321647,0.00001899623,0.0006875698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7021545,"threshold_uncertainty_score":0.999971,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09086108873478276,"score_gpt":0.3966181281528929,"score_spread":0.3057570394181102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}